J.P. Morgan Downgrades Shanghai Junshi Biosciences Co., Ltd. Class H (1877) to a Sell
TipRanksNov 13, 2024 07:09 ET
UBS Adjusts Shanghai Junshi Biosciences' Price Target to HK$65.40 From HK$70.90, Keeps at Buy
MT NewswiresSep 5, 2022 06:04 ET
No Data